In the first study performed on 64 SSc patients, Akamata et al. found no difference in circulating chemerin levels between SSc and controls, but this adipokine was reported to be significantly higher in patients with DUs as compared with those without DUs [225]. The gene discussed is RARRES2; the disease is systemic sclerosis.